Christopher Martell

Director/Board Member at CANDEL THERAPEUTICS, INC.

Net worth: 5 M $ as of 31/05/2026

47 year

4 connections

Finance

Consumer Services

Health Technology

Profile

Christopher Martell is currently an Independent Director at Candel Therapeutics, Inc. since 2018 and a Manager at Gtam1 2012 Adv LLC.
Former roles include Managing Director-Healthcare Investment Banking at J.P.
Morgan & Co., Inc. (Delaware) and Partner at PBM Capital Group LLC.
Education includes an undergraduate degree from Yale University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CANDEL THERAPEUTICS, INC. 0.75%	23/06/2026	546,863 ( 0.75% )	5 M $	31/05/2026

Christopher Martell active positions

Companies	Position	Start
CANDEL THERAPEUTICS, INC.	Director/Board Member	01/11/2018

All active positions of Christopher Martell

Former positions of Christopher Martell

Companies	Position	End
J.P. Morgan & Co., Inc. (Delaware) J.P. Morgan & Co., Inc. (Delaware) Financial ConglomeratesFinance Provides financial services	Corporate Officer/Principal	-
PBM Capital Group LLC PBM Capital Group LLC Investment ManagersFinance PBM Capital Group invests in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical and life sciences industries. They provide financing for buyout and early stage capital requirements.	Corporate Officer/Principal	-

See the detail of Christopher Martell's experience

Training of Christopher Martell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Martell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
PBM Capital Group LLC PBM Capital Group LLC Investment ManagersFinance PBM Capital Group invests in companies located in the United States. The firm targets companies operating in the fields of pharmaceutical and life sciences industries. They provide financing for buyout and early stage capital requirements.	Finance
Candel Therapeutics, Inc. Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer	Health Technology
J.P. Morgan & Co., Inc. (Delaware) J.P. Morgan & Co., Inc. (Delaware) Financial ConglomeratesFinance Provides financial services	Finance